About ImaginAb
ImaginAb is a company based in Los Angeles (United States) founded in 2007. It operates as a HealthTech. ImaginAb has raised $59.64 million across 6 funding rounds from investors including Novartis, Theravance Biopharma and HHS. ImaginAb offers products and services including CD8 ImmunoPET and PSMA Optical Imaging. ImaginAb operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others.
- Headquarter Los Angeles, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Imaginab, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$59.64 M (USD)
in 6 rounds
-
Latest Funding Round
$12.8 M (USD), Series C
Jun 03, 2021
-
Investors
Novartis
& 12 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ImaginAb
ImaginAb offers a comprehensive portfolio of products and services, including CD8 ImmunoPET and PSMA Optical Imaging. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advanced imaging agent for visualizing CD8 cell activity.
Optical imaging solution for prostate and renal cancer.
Unlock access to complete
Unlock access to complete
Funding Insights of ImaginAb
ImaginAb has successfully raised a total of $59.64M across 6 strategic funding rounds. The most recent funding activity was a Series C round of $12.8 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series C — $12.8M
-
First Round
First Round
(27 Sep 2011)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2021 | Amount | Series C - ImaginAb | Valuation | Norgine Ventures , Theravance Biopharma | |
| Sep, 2017 | Amount | Series B - ImaginAb | Valuation | Adage Capital Management | |
| Apr, 2016 | Amount | Series B - ImaginAb | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ImaginAb
ImaginAb has secured backing from 13 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Novartis, Theravance Biopharma and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment and strategic support are provided by Raptor Group.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Stage agnostic VC firm investing primarily in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ImaginAb
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ImaginAb
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Imaginab Comparisons
Competitors of ImaginAb
ImaginAb operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Natera and Strand Life Sciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Imaginab
Frequently Asked Questions about ImaginAb
When was ImaginAb founded?
ImaginAb was founded in 2007 and raised its 1st funding round 4 years after it was founded.
Where is ImaginAb located?
ImaginAb is headquartered in Los Angeles, United States. It is registered at Los Angeles, California, United States.
Is ImaginAb a funded company?
ImaginAb is a funded company, having raised a total of $59.64M across 6 funding rounds to date. The company's 1st funding round was a Series B of $5.34M, raised on Sep 27, 2011.
What does ImaginAb do?
ImaginAb is engaged in the development of cutting-edge radiopharmaceutical imaging technologies, primarily through its CD8 ImmunoPET agent, which is designed to provide detailed visual profiles of immunity status in patients. The company operates in the healthcare and biotechnology sectors, targeting immuno-oncology and autoimmune diseases. Solutions are offered to enhance patient care paths by enabling physicians to visualize treatment impacts before, during, and after therapy. Additionally, pipeline innovations include optical imaging for prostate and renal cancer, aiming to transform diagnostic and therapeutic approaches in oncology.
Who are the top competitors of ImaginAb?
ImaginAb's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
What products or services does ImaginAb offer?
ImaginAb offers CD8 ImmunoPET and PSMA Optical Imaging.
Who are ImaginAb's investors?
ImaginAb has 13 investors. Key investors include Novartis, Theravance Biopharma, HHS, Momentum Bioscience, and Raptor Group.